Nuveen Asset Management, LLC G1 Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 66,928 shares of GTHX stock, worth $478,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,928

Holding current value

$478,535

% of portfolio

0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.2 - $4.98 $147,241 - $333,301	66,928 New	66,928 $152,000
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $774,326 - $1.63 Million	-191,665 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $3.79 Million - $5.49 Million	-498,605 Reduced 72.23%	191,665 $1.59 Million
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $251,053 - $399,560	24,710 Added 3.71%	690,270 $7.05 Million
Q3 2021 Nov 12, 2021	SELL	$13.16 - $22.47 $2.91 Million - $4.97 Million	-221,080 Reduced 24.93%	665,560 $8.93 Million
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $3.91 Million - $5.26 Million	200,034 Added 29.13%	886,640 $19.5 Million
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $95,019 - $176,148	5,405 Added 0.79%	686,606 $16.5 Million
Q4 2020 May 17, 2021	SELL	$10.99 - $20.4 $199,292 - $369,933	-18,134 Reduced 2.59%	681,201 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $3.48 Million - $6.45 Million	316,336 Added 82.59%	699,335 $12.6 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $2.49 Million - $5.11 Million	215,243 Added 128.31%	382,999 $4.42 Million
Q2 2020 Aug 14, 2020	BUY	$9.57 - $24.37 $247,738 - $630,866	25,887 Added 18.25%	167,756 $4.07 Million
Q1 2020 May 14, 2020	BUY	$9.07 - $26.32 $93,620 - $271,675	10,322 Added 7.85%	141,869 $1.56 Million
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $37,814 - $57,071	-1,841 Reduced 1.38%	131,547 $3.48 Million
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $434,186 - $773,454	19,060 Added 16.67%	133,388 $3.04 Million
Q2 2019 Aug 15, 2019	BUY	$16.03 - $31.1 $1.83 Million - $3.56 Million	114,328 New	114,328 $3.51 Million

Others Institutions Holding GTHX

# of Institutions

101

Shares Held

20.1M

Call Options Held

1.87M

Put Options Held

1.18M

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC G1 Therapeutics, Inc. Transaction History